From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors
Open Access
- 8 December 2011
- journal article
- review article
- Published by Hindawi Limited in Clinical and Developmental Immunology
- Vol. 2011, 1-15
- https://doi.org/10.1155/2011/439053
Abstract
Unraveling the mechanisms used by the immune system to fight cancer development is one of the most ambitious undertakings in immunology. Detailed knowledge regarding the mechanisms of induction of tolerance and immunosuppression within the tumor microenvironment will contribute to the development of highly effective tumor eradication strategies. Research within the last few decades has shed more light on the matter. This paper aims to give an overview on the current knowledge of the main tolerance and immunosuppression mechanisms elicited within the tumor microenvironment, with the focus on development of effective immunotherapeutic strategies to improve homing and activity of immune effector cells to tumors.Keywords
This publication has 180 references indexed in Scilit:
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hostsCancer Immunology, Immunotherapy, 2008
- TGF-β: A Master of All T Cell TradesCell, 2008
- Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and PeripheryImmunity, 2008
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002